Design, synthesis, anticancer activity and molecular docking studies of new benzimidazole derivatives bearing 1,3,4-oxadiazole moieties as potential thymidylate synthase inhibitors — Abdulraheem S. A. Almalki (2022) | RDL Network
Design, synthesis, anticancer activity and molecular docking studies of new benzimidazole derivatives bearing 1,3,4-oxadiazole moieties as potential thymidylate synthase inhibitors
Article 2022 en
Authors
AA
Abdulraheem S. A. Almalki
SN
Syed Nazreen
SE
Serag Eldin I. Elbehairi
Abstract
1 min read
Compounds 10 and 14 arrest the cell cycle at the G1 phase and induce apoptosis without any necrosis in MDA-MB-231 cells.
Mohammad Mahboob Alam, Serag Eldin I. Elbehairi, Ali A. Shati, Rania A. Hussien, Mohammad Y. Alfaifi, Azizah M. Malebari, Mohammad Asad, Ahmed A. Elhenawy, Abdullah Mohamed Asiri, Ali Mahzari, Reem F. Alshehri, Syed Nazreen
Discussion(0)
No comments yet. Be the first to comment.